Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Cipla New Ventures

Profile and portfolio

Parent Cipla

Cipla New Ventures is the corporate venture arm of Cipla, a pharmaceutical and biotech company. Sectors it names: biotech and life sciences, healthcare and digital health.

Every figure links to its source

Snapshot

Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Companies backed4+companiesReported in the pressS1
Companies on the firm's portfolio page4companiesCounted from the firm's own listS1

Sources: S1 Global Venturing: Cipla considers new venture fund (2014-06-27).

Graphic 1 of 1

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S1 Global Venturing: Cipla considers new venture fund (2014-06-27).

Download:Report a correction

Where it invests

Geography

Investment regionsS2S1

Key facts

FactValueStatusSource
Parent companyCiplaSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Companies backed4+Single sourceS1

History

  1. Cipla sells its entire stake in Chase Pharma, reported four-fold return (2016-11-23)S3

Portfolio

Public sources name 4 portfolio companies.S1

Every company on the Cipla New Ventures list

4 companies, as named in the sources cited.S1 Read the firm's list.

  • BioMab
  • Chase Pharma
  • MabPharma
  • Stempeutics

Sources

  1. S1Global Venturing: Cipla considers new venture fund (2014-06-27)Press
  2. S2VCCircle: Cipla New Ventures head Chandru Chawla on investment strategy (2014-05-21)Press
  3. S3VCCircle: Cipla generates four-fold returns from Chase Pharma stake sale (2016-11-23)Press

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Cipla New Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.